Loading...
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Daratumumab (DARA) is a human CD38-specific IgG1 antibody that is in clinical development for the treatment of multiple myeloma (MM). The potential for IgG1 antibodies to induce macrophage-mediated phagocytosis, in combination with the known presence of macrophages in the tumor microenvironment in M...
Na minha lista:
| Udgivet i: | MAbs |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622648/ https://ncbi.nlm.nih.gov/pubmed/25760767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1007813 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|